Carlsmed (CARL) Stock: Buy, Sell, or Hold?
CARL - Carlsmed, Inc. Common Stock
$14.27
0.51 (3.71%)
▲
5d:
-5.5%
30d:
-12.67%
90d:
+16.11%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When CARL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CARL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CARL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CARL is currently trading at $14.27, which is considered oversold relative to its 30-day fair value range of $14.52 to $16.13.
Technical Outlook: Technically, CARL is in a strong uptrend. Immediate support is located at $13.45, while resistance sits at $15.85. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.20 (+34.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CARL is in a strong uptrend. Immediate support is located at $13.45, while resistance sits at $15.85. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.20 (+34.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$14.52 -
$16.13
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 34.5% below Wall St target ($19.20)
- NEUTRAL: Bottoming setup forming (40/100) — watch for confirmation
- CAUTION: 5-day price weakness (-5.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$14.52 -
$16.13
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.45
Resistance Level
$15.85
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-10.34
Wall Street Target
$19.20
(+34.5%)
Revenue Growth (YoY)
56.7%
Profit Margin
-57.4%
Share & Embed Analysis
Last updated: October 02, 2026 11:01 PM ET
Data refreshes hourly during market hours. Next update: 12:01 AM
Data refreshes hourly during market hours. Next update: 12:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CARL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 67 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 37 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 69 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 54 HOLD |